PACIRA PHARMACEUTICALS INC's ticker is PCRX and the CUSIP is 695127100. A total of 254 filers reported holding PACIRA PHARMACEUTICALS INC in Q3 2023. The put-call ratio across all filers is 0.88 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $84 | -24.3% | 2,739 | -1.5% | 0.00% | -25.0% |
| Q2 2023 | $111 | -2.6% | 2,781 | -0.6% | 0.00% | -20.0% |
| Q1 2023 | $114 | +5.6% | 2,797 | -0.4% | 0.01% | 0.0% |
| Q4 2022 | $108 | -99.9% | 2,807 | -17.7% | 0.01% | -28.6% |
| Q3 2022 | $181,000 | -27.6% | 3,411 | -20.6% | 0.01% | 0.0% |
| Q2 2022 | $250,000 | -0.8% | 4,296 | +30.3% | 0.01% | +16.7% |
| Q1 2022 | $252,000 | +10.5% | 3,296 | -12.9% | 0.01% | +20.0% |
| Q4 2021 | $228,000 | +8.1% | 3,783 | +0.3% | 0.01% | 0.0% |
| Q3 2021 | $211,000 | -11.7% | 3,771 | -4.1% | 0.01% | 0.0% |
| Q2 2021 | $239,000 | +141.4% | 3,931 | +178.2% | 0.01% | +150.0% |
| Q1 2021 | $99,000 | – | 1,413 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Gagnon Advisors, LLC | 251,140 | $19,167,000 | 8.83% |
| GAGNON SECURITIES LLC | 610,933 | $46,626,000 | 7.60% |
| Tamarack Advisers, LP | 205,000 | $15,646,000 | 7.40% |
| Spyglass Capital Management LLC | 1,871,040 | $142,798,000 | 4.88% |
| Lisanti Capital Growth, LLC | 302,413 | $23,080,000 | 2.59% |
| Rock Springs Capital Management LP | 1,000,000 | $76,320,000 | 1.92% |
| MESIROW FINANCIAL INVESTMENT MANAGEMENT - Fixed Income | 208,197 | $15,890,000 | 1.76% |
| JABODON PT CO | 49,052 | $3,744,000 | 1.70% |
| Zweig-DiMenna Associates LLC | 166,675 | $12,721,000 | 1.70% |
| NEUMEIER POMA INVESTMENT COUNSEL LLC | 317,425 | $24,226,000 | 1.63% |